Cargando…
Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression
BACKGROUND: Less than 30% of malignant gliomas respond to adjuvant chemotherapy. Here, we have asked whether variations in the constitutive expression of early-growth response factor 1 (EGR-1) predicted acute cytotoxicity and clonogenic cell death in vitro, induced by six different chemotherapics. M...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059282/ https://www.ncbi.nlm.nih.gov/pubmed/21366897 http://dx.doi.org/10.1186/1475-2867-11-5 |
_version_ | 1782200398529953792 |
---|---|
author | Calogero, Antonella Porcellini, Antonio Lombari, Vincenza Fabbiano, Cinzia Arcella, Antonietta Miscusi, Massimo Ponti, Donatella Ragona, Giuseppe |
author_facet | Calogero, Antonella Porcellini, Antonio Lombari, Vincenza Fabbiano, Cinzia Arcella, Antonietta Miscusi, Massimo Ponti, Donatella Ragona, Giuseppe |
author_sort | Calogero, Antonella |
collection | PubMed |
description | BACKGROUND: Less than 30% of malignant gliomas respond to adjuvant chemotherapy. Here, we have asked whether variations in the constitutive expression of early-growth response factor 1 (EGR-1) predicted acute cytotoxicity and clonogenic cell death in vitro, induced by six different chemotherapics. MATERIALS AND METHODS: Cytotoxicity assays were performed on cells derived from fresh tumor explants of 18 human cases of malignant glioma. In addition to EGR-1, tumor cultures were investigated for genetic alterations and the expression of cancer regulating factors, related to the p53 pathway. RESULTS: We found that sensitivity to cisplatin correlates significantly with levels of EGR-1 expression in tumors with wild-type p53/INK4a/p16 status. CONCLUSION: Increased knowledge of the mechanisms regulating EGR-1 expression in wild-type p53/INK4a/p16 cases of glioma may help in the design of new chemotherapeutic strategies for these tumors. |
format | Text |
id | pubmed-3059282 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30592822011-03-17 Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression Calogero, Antonella Porcellini, Antonio Lombari, Vincenza Fabbiano, Cinzia Arcella, Antonietta Miscusi, Massimo Ponti, Donatella Ragona, Giuseppe Cancer Cell Int Primary Research BACKGROUND: Less than 30% of malignant gliomas respond to adjuvant chemotherapy. Here, we have asked whether variations in the constitutive expression of early-growth response factor 1 (EGR-1) predicted acute cytotoxicity and clonogenic cell death in vitro, induced by six different chemotherapics. MATERIALS AND METHODS: Cytotoxicity assays were performed on cells derived from fresh tumor explants of 18 human cases of malignant glioma. In addition to EGR-1, tumor cultures were investigated for genetic alterations and the expression of cancer regulating factors, related to the p53 pathway. RESULTS: We found that sensitivity to cisplatin correlates significantly with levels of EGR-1 expression in tumors with wild-type p53/INK4a/p16 status. CONCLUSION: Increased knowledge of the mechanisms regulating EGR-1 expression in wild-type p53/INK4a/p16 cases of glioma may help in the design of new chemotherapeutic strategies for these tumors. BioMed Central 2011-03-02 /pmc/articles/PMC3059282/ /pubmed/21366897 http://dx.doi.org/10.1186/1475-2867-11-5 Text en Copyright ©2011 Calogero et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Primary Research Calogero, Antonella Porcellini, Antonio Lombari, Vincenza Fabbiano, Cinzia Arcella, Antonietta Miscusi, Massimo Ponti, Donatella Ragona, Giuseppe Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression |
title | Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression |
title_full | Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression |
title_fullStr | Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression |
title_full_unstemmed | Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression |
title_short | Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression |
title_sort | sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of egr-1 expression |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059282/ https://www.ncbi.nlm.nih.gov/pubmed/21366897 http://dx.doi.org/10.1186/1475-2867-11-5 |
work_keys_str_mv | AT calogeroantonella sensitivitytocisplatininprimarycelllinesderivedfromhumangliomacorrelateswithlevelsofegr1expression AT porcelliniantonio sensitivitytocisplatininprimarycelllinesderivedfromhumangliomacorrelateswithlevelsofegr1expression AT lombarivincenza sensitivitytocisplatininprimarycelllinesderivedfromhumangliomacorrelateswithlevelsofegr1expression AT fabbianocinzia sensitivitytocisplatininprimarycelllinesderivedfromhumangliomacorrelateswithlevelsofegr1expression AT arcellaantonietta sensitivitytocisplatininprimarycelllinesderivedfromhumangliomacorrelateswithlevelsofegr1expression AT miscusimassimo sensitivitytocisplatininprimarycelllinesderivedfromhumangliomacorrelateswithlevelsofegr1expression AT pontidonatella sensitivitytocisplatininprimarycelllinesderivedfromhumangliomacorrelateswithlevelsofegr1expression AT ragonagiuseppe sensitivitytocisplatininprimarycelllinesderivedfromhumangliomacorrelateswithlevelsofegr1expression |